Buscar
Mostrando ítems 1-10 de 34
Mechanisms of antibiotic resistance in enterococci
(Informa, 2014)
Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to virtually all antimicrobials currently used in clinical practice using ...
Mechanisms of antibiotic resistance in enterococci
(Informa, 2014)
Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to virtually all antimicrobials currently used in clinical practice using ...
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
(Elsevier, 2014)
Treatment of severe infections caused by vancomycin-resistant enterococci (VRE) is challenging due to the scarcity of reliable therapeutic alternatives. In this context, daptomycin (DAP), a lipopeptide antibiotic, has ...
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
(Elsevier, 2014)
Treatment of severe infections caused by vancomycin-resistant enterococci (VRE) is challenging due to the scarcity of reliable therapeutic alternatives. In this context, daptomycin (DAP), a lipopeptide antibiotic, has ...
What's New in the Treatment of Enterococcal Endocarditis?
(Springer, 2014)
Enterococcus spp. are among the common pathogens causing infective endocarditis (IE). Despite major medical advances and new potent antimicrobial agents, the mortality has not significantly improved for several decades. ...
Enterococcal endocarditis: can we win the war?
(Springer, 2012)
Treatment of enterococcal infections has long been recognized as an important clinical challenge, particularly in the setting of infective endocarditis (IE). Furthermore, the increase prevalence of isolates exhibiting ...
Enterococcal endocarditis: can we win the war?
(Springer, 2012)
Treatment of enterococcal infections has long been recognized as an important clinical challenge, particularly in the setting of infective endocarditis (IE). Furthermore, the increase prevalence of isolates exhibiting ...
What's New in the Treatment of Enterococcal Endocarditis?
(Springer, 2014)
Enterococcus spp. are among the common pathogens causing infective endocarditis (IE). Despite major medical advances and new potent antimicrobial agents, the mortality has not significantly improved for several decades. ...
Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group
(Oxford University Press, 2017)
Antimicrobial resistance in gram-positive bacteria remains a challenge in infectious diseases. The mission of the Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG) is to advance knowledge in ...